Endocannabinoid
EndogenousPDCPentadecanoylcarnitine
3-pentadécanoyloxy-4-(triméthylazaniumyl)butanoate
Aliases.pentadecanoylcarnitine · C15:0 carnitine · O-pentadécanoylcarnitine · pentadécanoyl-L-carnitine
The carnitine ester of a dairy fatty acid, described in 2022 as a full agonist of CB1 and CB2 at micromolar concentration.
Updated on
Level of detail
Identifiers
- Formula
- C₂₂H₄₃NO₄
- Molar mass
- 385.60 g·mol⁻¹
- CAS
- -
- PubChem CID
- 123132011
- Origin
- An endogenous compound. It is the carnitine metabolite of pentadecanoic acid, a saturated fifteen-carbon fatty acid supplied by the diet, mainly by dairy fats and certain seafood products. Its presence in the body therefore depends directly on the dietary intake of that odd-chain fatty acid.
- InChIKey
- MDDWQHVKSHTZTD-UHFFFAOYSA-N
In plain terms
Pentadecanoylcarnitine comes from a fatty acid found mainly in dairy products. Its first role is to help fats enter the mitochondria. A screen in 2022 additionally found it active at the receptors of the endocannabinoid system, at high concentrations however.
Receptors and activity
- CB1EC50 = 3,7 µMAgonist
- CB2EC50 = 3,2 µMAgonist
- 5-HT1AAgonist
- Agonist
- Partial agonist
- Antagonist
- Modulator
- Inverse agonist
Hover over a row for the precise value (Ki, EC50…)
Subjective signature
Hover over an axis to read its definition.
- Calm35
- Clarity15
- Sleep25
- Appetite10
- High20
Editorial estimate, not clinical.
Pharmacology
Pentadecanoylcarnitine is the carnitine ester of pentadecanoic acid, a saturated fifteen-carbon fatty acid that the body receives essentially from dairy fats. Its established function is metabolic: carnitine esters constitute the form in which fatty acids cross the inner mitochondrial membrane before their oxidation. Venn-Watson and colleagues attributed to it in 2022 a second, signalling function, at the end of a screen covering 148 biomarkers spread over twelve primary human cell systems and 78 target assays. The compound there behaved as a full agonist of both cannabinoid receptors, with median effective concentrations of 3.7 micromolar at CB1 and 3.2 micromolar at CB2 and maximal effects slightly above those of the positive control, which led the authors to present it as the second full agonist endocannabinoid identified. The same work noted agonist activity at the 5-HT1A and 5-HT1B receptors, antagonist activity at the H1 and H2 receptors, and dose-dependent anti-inflammatory effects marked by falls in interleukin 1 alpha, ITAC, MCP-1 and IP-10. Two caveats accompany the reading of these results. The effective concentrations lie in the micromolar range, far above those of the reference endocannabinoid ligands, and the authors declare interests with the companies that exploit odd-chain fatty acids commercially. Independent confirmation of these activities remains to be established.
Biosynthetic pathway (in vivo)
The molecule is neither an N-acylethanolamine nor a monoacylglycerol, unlike the classical endocannabinoids: it is a carnitine ester. It forms by transfer of pentadecanoic acid, activated as a coenzyme A thioester, onto the hydroxyl function of L-carnitine, a reaction catalysed by the carnitine acyltransferases. That esterification is the step that allows fatty acids to cross the inner mitochondrial membrane, upstream of their oxidation. The compound is therefore originally an intermediate of fatty acid transport, whose signalling activity constitutes a second function.
Legal framework
France
An endogenous substance, listed neither among narcotics nor among psychotropics. The pentadecanoic acid from which it comes is a normal dietary constituent, present in dairy products. No particular status attaches to the metabolite itself, which is not marketed as such in France.
European Union
Not controlled. The compound is covered by no European control decision. Any nutritional or health claim concerning the fatty acid from which it derives would fall under the assessment of the European Food Safety Authority, which has not ruled on this metabolite.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Structural classification
- Class
- Endocannabinoid
- Origin
- An endogenous compound. It is the carnitine metabolite of pentadecanoic acid, a saturated fifteen-carbon fatty acid supplied by the diet, mainly by dairy fats and certain seafood products. Its presence in the body therefore depends directly on the dietary intake of that odd-chain fatty acid.
- Status
- Endogenous
References
Structured data
- InChIKey
- MDDWQHVKSHTZTD-UHFFFAOYSA-N
- SMILES
- CCCCCCCCCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C
- Formula
- C22H43NO4
- Molar mass
- 385.60 g·mol⁻¹
- PubChem CID
- 123132011
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.